In this episode of On Boards, hosts Joe Ayoub and Raza Shaikh speak with Dr. Linda McGoldrick, an international board director, strategy leader, and policy expert in healthcare and life sciences.

With 30 years of global experience across the U.S., U.K., and European boards, Linda shares what defines high-performing boards, the importance of trust and diversity of thought, and how geopolitical and technological shifts are transforming governance today.

Key takeaways

• Traits of high performing boards

• Regardless of size or geography, effective boards are well-prepared, prioritize meaningful discussion over reporting, and cultivate trust and mutual respect.

• High performing boards all display strong relationships, open communication, and diversity of thought among board members.

• Linda added that values, camaraderie and trust are intangible aspects that are important aspects of a successful board.

• Boards in the U.S. vs the rest of the world

• Linda observed that even in non-English speaking countries, English serves as the universal language for board communications - a reflection of its role as the global language of business

• Boards outside the U.S. place greater emphasis on courtesy, respect, and a thoughtful pace of discussion, reflecting multicultural membership and diverse business contexts.

• Historically, many U.S. boards were more domestically focused, but Linda sees this shifting as companies expand internationally. Directors today are expected to understand global markets, geopolitical dynamics, and comparative business environments.

• Expansion of risk oversight

• Today's boards must monitor not only financial and operational risks but also a host of geopolitical, regulatory, and other related challenges.

• Artificial intelligence impact on boards

• The use of AI has implications of security, benefits, risk and investment as the technology continues to expand and have impacts on economies and society.

• Boards have the responsibility to oversee the implications for organizational strategy and risk management.

• Linda views AI as a valuable efficiency tool, such as bots that summarize materials but stresses that human judgment, discretion, and ethics must remain central to board decision-making.

Quotes

"I don't want to see myself around the table. I want to see a diversity of experience. We all bring certain talents which feed into the most rigorous and robust discussions around board process."

"AI is a global race… I think the human element of discretion and insight is critical to know the line of technical and bot-expertly-fed conversations versus human thoughtful conversations in dialogue.

Guest Bio

Dr. Linda McGoldrick is an international board director and healthcare and life sciences leader with more than 30 years of global executive and governance experience. She serves on the boards of SmileyLife Holding, Alvotech, where she chairs the Audit Committee, and Compass Pathways, and is the Founder and CEO of Financial Health Associates International.

Linda has held senior roles across the U.S. and Europe, including leadership positions at Marsh's Healthcare & Life Sciences practice, Kaiser Permanente's European operations, and Veos plc. She has also served as CEO of the International Diabetes Federation and the Drug Information Association.

A dual U.S.–U.K. citizen, Linda brings deep expertise in global strategy, regulatory environments, and board governance across public, private, and nonprofit organizations.